Increased expression of Matrix Metalloproteinase 9 in liver from NZB/W F1 mice received antibody against human parvovirus B19 VP1 unique region protein

Journal of Biomedical Science

Volumn 16, Issue 1, 2009, Pages

  Tsai, Chun Chou ^a   Tzang, Bor Show ^a   Chiang, Szu Yi ^b   Hsu, Gwo Jong ^c   Hsu, Tsai Ching ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b Hualien Hospital   (Taiwan)

^c CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

B19 VPI ANTIBODY; DOUBLE STRANDED DNA; GELATINASE B; IMMUNOGLOBULIN G; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; UNCLASSIFIED DRUG; VIRUS ANTIBODY; AUTOANTIBODY; GELATINASE A; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DRUG EFFECT; MOUSE; NONHUMAN; PARVOVIRUS; PARVOVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; ANTIPHOSPHOLIPID SYNDROME; ENZYMOLOGY; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; LIVER; METABOLISM; RABBIT; SYSTEMIC LUPUS ERYTHEMATOSUS;

MUS; ORYCTOLAGUS CUNICULUS; PARVOVIRUS;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HUMANS; LIVER; LUPUS ERYTHEMATOSUS, SYSTEMIC; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; PARVOVIRUS B19, HUMAN; RABBITS; VIRAL PROTEINS;

EID: 63449105532     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-16-14     Document Type: Article

References (33)

1. Parvovirus B19. NS Young KE Brown, N Engl J Med 2004 350 586 597 10.1056/NEJMra030840 14762186
2. The production of human parvovirus capsid proteins in Escherichia coli and their potential as diagnostic antigens. FB Rayment E Crosdale DJ Morris JR Pattison P Talbot JJ Clare, J Gen Virol 1990 71 2665 2672 10.1099/0022-1317-71- 11-2665 1701479
3. The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity. S Dorsch G Liebisch B Kaufmann P von Landenberg JH Hoffmann W Drobnik S Modrow, J Virol 2002 76 2014 2018 11799199 10.1128/JVI.76.4.2014- 2018.2002
4. Interfacial enzymology of parvovirus phospholipases A2. S Canaan Z Zádori F Ghomashchi J Bollinger M Sadilek ME Moreau P Tijssen MH Gelb, J Biol Chem 2004 279 14502 14508 10.1074/jbc.M312630200 14726513
5. Activation of Synoviocytes by the Secreted Phospholipase A2 Motif in the VP1-Unique Region of Parvovirus B19 Minor Capsid Protein. J Lu N Zhi S Wong KF Brown, J Infect Dis 2006 193 582 590 10.1086/499599 16425138
6. VP1u phospholipase activity is critical for infectivity of full-length parvovirus B19 genomic clones. C Filippone N Zhi S Wong J Lu S Kajigaya G Gallinella L Kakkola M Söderlund-Venermo NS Young KE Brown, Virology 2008 374 444 452 10.1016/j.virol.2008.01.002 18252260
7. Parvovirus B19 infection and autoimmune disease. HW Lehmann S Modrow, Autoimmun Rev 2003 2 218 223 10.1016/S1568-9972(03)00014-4 12848949
8. Human parvovirus B19 infection and antiphospholipid-syndrome: the two sides of one medal. P von Landenberg S Modrow, J Vet Med B Infect Dis Vet Public Health 2005 52 353 355 16316400
9. Human parvovirus B19 infection and antiphospholipid antibodies. P von Landenberg HW Lehmann S Modrow, Autoimmun Rev 2007 6 278 285 10.1016/j.autrev.2006.09.006 17412298
10. Similarities of specificity and cofactor dependence in serum antiphospholipid antibodies from patients with human parvovirus B19 infection and from those with systemic lupus erythematosus. S Loizou JK Cazabon MJ Walport D Tait AK So, Arthritis Rheum 1997 40 103 108 10.1002/art.1780400115 9008606
11. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection. P von Landenberg HW Lehmann A Knoll S Dorsch S Modrow, Arthritis Rheum 2003 48 1939 1947 10.1002/art.11038 12847688
12. The association of VP1 unique region protein in acute parvovirus B19 infection and antiphospholipid antibody production. BS Tzang GJ Tsay YJ Lee C Li YS Sun TC Hsu, Clin Chim Acta 2007 378 59 65 10.1016/j.cca.2006.10.016 17169353
13. Induction of antiphospholipid antibodies and antiphospholipid syndrome-like autoimmunity in naive mice with antibody against human Parvovirus B19 VP1 unique region protein. BS Tzang YJ Lee TP Yang GJ Tsay JY Shi CC Tsai TC Hsu, Clin Chim Acta 2007 382 31 36 10.1016/j.cca.2007.03.014 17451664
14. Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. M Blank J Cohen V Toder Y Shoenfeld, Proc Natl Acad Sci USA 1991 88 3069 3073 2014226 10.1073/pnas.88.8.3069
15. Beneficial effects of treatment with transglutaminases inhibitor cystamine on macrophage response in NZB/W F1 mice. TC Hsu SY Chiang CY Huang GJ Tsay CW Yang CN Huang BS Tzang, Exp Biol Med 2007 232 195 203 17259326
16. Up-regulation of adhesion molecule expression and induction of TNF- on vascular endothelial cells by antibody against human parvovirus B19 VP1 unique region protein. BS Tzang CC Tsai CC Chiu JY Shi TC Hsu, Clin Chim Acta 2008 395 77 83 10.1016/j.cca.2008.05.012 18538665
17. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. MM Bradford, Anal Biochem 1976 72 248 254 10.1016/0003-2697(76)90527-3 942051
18. Differential inductions of matrix metalloproteinase-2 and -9 in host tissues during the growth of ascitic sarcoma 180 cells in mice. WH Kuo SF Yang SC Chu SO Lu FP Chou YS Hsieh, Cancer Lett 2003 189 103 112 10.1016/S0304- 3835(02)00323-3 12445684
19. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheet: procedure and some applications. H Towbin T Staehelin J Gordon, Proc Natl Acad Sci USA 1979 76 4350 4354 388439 10.1073/pnas.76.9.4350
20. Beta-2-glycoprotein-I, infections, antiphospholipid syndrome and therapeutic considerations. M Blank Y Shoenfeld, Clin Immunol 2004 112 190 199 10.1016/j.clim.2004.02.018 15240163
21. Management of antiphospholipid antibody syndrome: a systematic review. W Lim MA Crowther JW Eikelboom, JAMA 2006 295 1050 1057 10.1001/jama.295.9.1050 16507806
22. Infectious origin of the antiphospholipid syndrome. Y Shoenfeld M Blank R Cervera J Font E Raschi PL Meroni, Ann Rheum Dis 2006 65 2 6 16344491 10.1136/ard.2005.045443
23. The infectious etiology of the antiphospholipid syndrome: links between infection and autoimmunity. M Harel A Aron-Maor Y Sherer M Blank Y Shoenfeld, Immunobiology 2005 210 743 747 10.1016/j.imbio.2005.10.004 16325492
24. Induction of antiphospholipid antibodies by immunization with synthetic viral and bacterial peptides. EE Gharavi H Chaimovich E Cucurull CM Celli H Tang WA Wilson AE Gharavi, Lupus 1999 8 449 455 10.1177/096120339900800607 10483013
25. Matrix metalloproteinases and immunity. EJ Goetzl MJ Banda D Leppert, J Immunol 1996 156 1 4 8598448
26. Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications. S Zucker M Hymowitz C Conner HM Zarrabi AN Hurewitz L Matrisian D Boyd G Nicolson S Montana, Ann N Y Acad Sci 1999 878 212 227 10.1111/j.1749-6632.1999. tb07687.x 10415733
27. A turner and amplifier of immune functions. G Opdenaker PE Van der Steen J Van Damme B Gelatinase, Trends Immunol 2001 22 571 579 10.1016/S1471-4906(01) 02023-3 11574282
28. Matrix Metalloproteinase-9 and autoimmune diseases. M Ram Y Sherer Y Shoenfeld, J Clin Immunol 2006 26 299 307 10.1007/s10875-006-9022-6 16652230
29. Activity of matrix metalloproteinase-9 is elevated in sera of patients with systemic lupus erythematosus. A Faber-Elmann Z Sthoeger A Tcherniack M Dayan E Mozes, Clin Exp Immunol 2002 127 393 398 11876767 10.1046/j.1365-2249. 2002.01758.x
30. Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities. H Ainiala A Hietaharju P Dastidar J Loukkola T Lehtimäki J Peltola M Korpela T Heinonen ST Nikkari, Arthritis Rheum 2004 50 858 865 10.1002/art.20045 15022328
31. Beneficial effects of treatment with cystamine on brain in NZB/W F1 mice. TC Hsu YC Chen WX Lai SY Chiang CY Huang BS Tzang, Eur J Pharmacol 2008 591 307 314 10.1016/j.ejphar.2008.06.078 18621044
32. Cyclophilin A up-regulates MMP-9 expression and adhesion of monocytes/macrophages via CD147 signalling pathway in rheumatoid arthritis. Y Yang N Lu J Zhou ZN Chen P Zhu, Rheumatology 2008 47 1299 310 10.1093/rheumatology/ken225 18567920
33. IL-1 beta induces proMMP-9 expression via c-Src-dependent PDGFR/PI3K/Akt/p300 cascade in rat brain astrocytes. CY Wu HL Hsieh CC Sun CP Tseng CM Yang, J Neurochem 2008 105 1499 1512 10.1111/j.1471-4159.2008.05318.x 18315570